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Abstract
Background:	Wireless	motility	 capsule	 (WMC)	 findings	 are	 incompletely	 defined	 in	
suspected gastroparesis. We aimed to characterize regional WMC transit and contrac-
tility in relation to scintigraphy, etiology, and symptoms in patients undergoing gastric 
emptying testing.
Methods:	A	total	of	209	patients	with	gastroparesis	symptoms	at	NIDDK	Gastroparesis	
Consortium centers underwent gastric scintigraphy and WMCs on separate days to 
measure	 regional	 transit	 and	 contractility.	 Validated	 questionnaires	 quantified	
symptoms.
Key Results:	 Solid	 scintigraphy	 and	 liquid	 scintigraphy	were	 delayed	 in	 68.8%	 and	
34.8%	of	patients;	WMC	gastric	 emptying	 times	 (GET)	were	delayed	 in	40.3%	and	
showed	 52.8%	 agreement	 with	 scintigraphy;	 15.5%	 and	 33.5%	 had	 delayed	 small	
bowel	(SBTT)	and	colon	transit	(CTT)	times.	Transit	was	delayed	in	≥2	regions	in	23.3%.	
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1  | INTRODUCTION
Gastroparesis presents with nausea, vomiting, early satiety, fullness, 
bloating, and pain with objective evidence of delayed gastric empty-
ing.1 The diagnosis of gastroparesis may be made by scintigraphy or 
by gastric emptying breath testing.2-4 A third method, wireless motil-
ity	capsule	 (WMC)	testing,	 is	approved	to	quantify	gastric	emptying	
in	suspected	gastroparesis	by	detecting	pH	increases	as	the	capsule	
passes from the stomach to duodenum.5 WMC gastric emptying times 
correlated well with scintigraphic emptying in a smaller prior report.5
Although presumed to originate in the stomach, gastroparesis 
symptoms	 are	 non-	specific	 and	 may	 be	 reported	 with	 other	 lower	
functional gastrointestinal disorders.6,7 Gastroparesis patients also 
describe bowel disturbances suggesting involvement of multiple gut 
regions.8,9 WMC methods offer expanded capabilities over scintigra-
phy, providing small bowel and colon transit measurements in gener-
alized motility disorders.10-12 Retrospective WMC series have defined 
extragastric transit delays in some patients with presumed gastropa-
resis.13,14 The WMC pressure sensor estimates contractility in differ-
ent gut regions.15 Reduced gastric and colon contractions have been 
defined in small gastroparesis cohorts.16,17	However,	abnormalities	of	
transit and contractility in different gut regions have not been con-
trasted in patients with diabetic versus idiopathic gastroparesis.
The importance of gastric and extragastric transit and contrac-
tility abnormalities in causing gastroparesis symptoms is unproved. 
Symptom	 severities	 measured	 using	 standardized	 questionnaires	
from a large registry of patients with such symptoms were not differ-
ent in those with delayed versus normal gastric emptying measured 
by scintigraphy.18 In that report, a novel patient subgroup with sim-
ilar symptoms as gastroparesis but with normal emptying, termed 
chronic	 unexplained	 nausea	 and	 vomiting	 (CUNV),	 was	 defined.	 In	
one retrospective WMC assessment of patients with generalized 
dysmotility symptoms, upper and lower gut symptoms did not pre-
dict transit abnormalities.12	However,	duodenal	contractility	on	WMC	
tests negatively correlated with overall symptom severity in another 
small gastroparesis cohort.19	 Drawbacks	 of	 older	 WMC	 studies	 in	
gastroparesis include their retrospective nature, small sample sizes, 
non-	standardized	gastric	scintigraphy	methods,	and	lack	of	symptom	
characterizations using validated surveys.
This investigation related prospective WMC data from a large, 
multicenter	 cohort	 from	 the	 NIDDK	 Gastroparesis	 Consortium	 to	
standardized gastric scintigraphy findings and gastrointestinal symp-
toms	 quantified	 by	 validated	 questionnaires.	 Specific	 aims	were	 to:	 
(i)	characterize	WMC	gastric	and	extragastric	transit	and	contractility	
in suspected gastroparesis, including comparisons in diabetic versus 
idiopathic	patients,	(ii)	associate	gastric	emptying	delays	measured	by	
Rapid	 transit	was	 rarely	 observed.	Diabetics	 had	 slower	GET	 but	more	 rapid	 SBTT	
versus idiopathics (P	≤	.02).	 GET	 delays	 related	 to	 greater	 scintigraphic	 retention,	
slower	SBTT,	and	fewer	gastric	contractions	(P	≤	.04).	Overall	gastroparesis	symptoms	
and nausea/vomiting, early satiety/fullness, bloating/distention, and upper abdominal 
pain subscores showed no relation to WMC transit. Upper and lower abdominal pain 
scores (P	≤	.03)	were	greater	with	 increased	colon	contractions.	Constipation	corre-
lated with slower CTT and higher colon contractions (P	=	.03).	Diarrhea	scores	were	
higher	with	delayed	SBTT	and	CTT	(P	≤	.04).
Conclusions & Inferences: Wireless motility capsules define gastric emptying delays 
similar but not identical to scintigraphy that are more severe in diabetics and relate to 
reduced	gastric	contractility.	Extragastric	transit	delays	occur	in	>40%	with	suspected	
gastroparesis. Gastroparesis symptoms show little association with WMC profiles, al-
though lower symptoms relate to small bowel or colon abnormalities.
K E Y W O R D S
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Key Points
•	 Wireless	 motility	 capsule	 (WMC)	 findings	 in	 suspected	
gastroparesis and relations to symptoms have been 
poorly defined.
• Evaluation of patients with gastroparesis symptoms re-
vealed gastric emptying delays with WMCs that were 
similar to scintigraphy, were related to reduced contrac-
tility, and were often associated with extragastric or gen-
eralized transit delays; symptoms correlated poorly with 
WMC profiles.
• These findings provide insight into motor abnormalities in 
gastroparesis pathogenesis and form a basis for future 
investigations studying the impact of WMC testing on 
clinical care.
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WMC and scintigraphy with other transit and contractility measures in 
suspected	gastroparesis	and	provide	insight	into	CUNV	pathogenesis,	
and	(iii)	relate	symptom	severity	to	WMC	transit	and	contractility	to	
ascribe potential pathogenic roles for motor dysfunction to symptom 
genesis. These analyses defined the breadth and pathophysiologic im-
portance of motor abnormalities in suspected gastroparesis to form a 
foundation for future studies investigating the impact of WMC testing 
on	decision	making	and	outcomes.	Some	data	within	this	study	were	
presented	at	Digestive	Disease	Week	in	2015	and	2016.20,21
2  | MATERIALS AND METHODS
2.1 | Patient populations
Two hundred and nine patients with suspected gastroparesis under-
went WMC testing after enrollment in the Gastroparesis Registry 
2	 (GpR2)	 at	 the	 8	 centers	 of	 the	 Gastroparesis	 Clinical	 Research	
Consortium	(GpCRC)	from	March	2013	to	March	2016	(ClinicalTrials.
gov	 NCT01696747).	 Patients	 reported	 gastroparesis	 symptoms	
≥12	weeks	of	duration	and	showed	no	organic	disease	on	endoscopy	
within 12 months before enrollment. WMC testing was not per-
formed	 in	patients	with	known	bezoars	 (poorly	organized	food	resi-
due	was	permitted),	dysphagia,	prior	gut	surgery,	GI	strictures,	prior	
inflammatory	 bowel	 disease	 or	 diverticulitis,	 frequent	 nonsteroidal	
anti-	inflammatory	drug	use,	and	cardiac	medical	devices	(gastric	stim-
ulators,	insulin	pumps,	glucose	monitors	were	permitted).	Attribution	
of gastroparesis to diabetic versus idiopathic versus other etiologies 
was	made	by	site	investigators	based	on	patient	self-	report	and	medi-
cal record review. Within 6 months before GpR2 enrollment, patients 
underwent	scintigraphy	to	quantify	solid	and	liquid	gastric	emptying.	
The	 solid-	phase	meal	was	 comprised	of	 99mTc-	sulfur	 colloid-	labeled	
egg	 substitute	meals	which	 included	120	g	EggBeaters®, 2 slices of 
bread,	30	g	strawberry	jam,	and	120	mL	water	(255	kcal,	72%	carbo-
hydrate,	24%	protein,	2%	fat,	2%	fiber).3	One	hundred	and	forty-	nine	
of	 the	 209	 patients	 underwent	 concurrent	 liquid	 gastric	 emptying	
scintigraphy with consumption of 120 mL 111In-	DTPA	(diethylenetri-
aminepentaacetic	acid)-	labeled	water	along	with	the	solid	meal.22
Studies	were	approved	by	Institutional	Review	Boards	at	all	Clinical	
Centers and the Data Coordinating Center. Patients provided written 
informed consent. All authors had access to study data and reviewed 
and approved the final manuscript.
2.2 | WMC testing
Patients underwent WMC (SmartPill®;	Medtronic,	Minneapolis,	MN,	
USA)	 testing	 using	 accepted	 protocols.14,15,23 The WMC measures 
26.8 mm × 11.7 mm and transmits data to a receiver. WMC sensors 
measure	intraluminal	pH	(every	5	seconds	for	the	first	24	hours,	every	
10	seconds	from	24	to	48	hours,	and	every	2.5	minutes	after	48	hours;	
accurate	 to	 ±0.5	 pH	 units),	 pressure	 from	 0	 to	 350	mm	Hg	 (every	
0.5	seconds	for	the	first	24	hours,	every	second	afterward;	accurate	
to	 ±5	mm	Hg	 <100	mm	Hg	 and	 ±10%	 >100	mm	Hg),	 and	 tempera-
ture	from	25	to	49°C	(every	20	seconds	for	the	first	24	hours,	every	
40	seconds	afterward;	accurate	to	±1°C).14,15,23	Before	WMC	testing,	
patients stopped proton pump inhibitors for 7 days, and histamine2-	
receptor	 antagonists,	 prokinetics	 (metoclopramide,	 domperidone,	
erythromycin),	 opiates,	 anticholinergics,	 cannabinoids,	 over-	the-	
counter laxatives, isotonic polyethylene glycol electrolyte prepara-
tions,	and	prescription	laxatives	(lubiprostone,	linaclotide,	misoprostol)	
for	3	days.	On	the	evening	before	testing,	 insulin-	requiring	diabetics	
injected	 half	 of	 their	 usual	 long-	acting	 insulin	 dose.	 Patients	 fasted	
overnight before testing. Urine pregnancy tests were performed for 
female	patients	of	child-	bearing	potential	on	the	day	of	WMC	inges-
tion.	 Fingerstick	 glucose	 measurements	 were	 made	 in	 diabetic	 pa-
tients; studies were rescheduled if fasting glucose levels exceeded 
270	mg/dL.	 Each	 patient	 then	 ingested	 one	 SmartBar®	 (Medtronic)	
with similar caloric content as the radiolabelled egg substitute meal 
(255	kcal,	 66%	 carbohydrate,	 17%	 protein,	 2%	 fat,	 3%	 fiber)	 over	
10	minutes	with	≤50	mL	water.	After	consuming	the	SmartBar®, the 
WMC	was	 swallowed	with	another	50	mL	of	water.	Patients	 fasted	
for 6 hours after WMC ingestion and then resumed normal diets. They 
were	instructed	to	keep	the	data	receiver	within	3	feet	of	their	bodies	
at	all	times	for	the	next	4-	7	days	until	they	returned	the	data	receiver.	
Patients continued to abstain from proton pump inhibitors and medi-
cations	that	influence	gut	transit	over	this	4-	to	7-	day	period.
Gastric	 emptying	 times	 (GET)	were	 calculated	 from	 the	 time	 of	
WMC ingestion to when the capsule passed into the duodenum, as 
defined	by	abrupt	≥2	pH	unit	increases	from	the	lowest	postprandial	
value	to	levels	≥4	that	persisted	for	at	least	10	minutes.	WMC	ileocecal	
junction	transit	was	detected	when	pH	decreased	≥1.0	pH	unit	for	at	
least	10	minutes	≥30	minutes	after	pyloric	passage.	WMC	small	bowel	
transit	times	(SBTT)	were	calculated	from	the	end	of	the	GET	period	
to ileocecal junction passage. Anal WMC evacuation was detected by 
abrupt	 0.025°C	 per	 second	 decreases	 in	 temperature.	WMC	 colon	
transit	times	(CTT)	were	calculated	from	the	end	of	the	SBTT	period	to	
the	time	of	anal	capsule	expulsion.	WMC	contractions	>10	mmHg	in	
amplitude	were	quantified	in	the	hour	before	GET	to	measure	gastric	
contractility while contractions in the hour after GET determined small 
bowel contractility as described previously.13	Motility	 indices	 (MI)	 in	
the	hour	before	(gastric)	and	after	GET	(small	bowel)	were	calculated	
from the logarithmic transformation of the areas under the contraction 
curves.	Numbers	of	 contractions	>25	mm	Hg	 in	 amplitude	per	 hour	
and MI were calculated for the entire period of colon transit using 
accepted methods.24	 Normal	 gastric	 emptying	 times	 (GET)	 (≤5	 and	
>1:45	hours),	small	bowel	transit	times	 (SBTT)	 (≤6	and	>2:15	hours),	
and	colon	transit	times	(CTT)(≤58:45	and	>4:30	hours)	were	defined	
in a recent report.23	 Severely	 delayed	GET	 (>12	hours)	was	 defined	
as previously.16	Numbers	of	contractions	and	motility	indices	(MI)	for	
each region were calculated as measures of contractility.16,23	Numbers	
of	gastric	and	small	bowel	contractions	<29/hour	and	<36/hour	and	
gastric	and	small	bowel	MI	<9.82	and	<10.57,	respectively,	have	been	
defined	as	below	the	5th	percentile	for	normal	volunteers.16	Normal	
cutoffs for numbers of contractions and MI for the colon have not 
been defined. Patients also were stratified into those with high versus 
low contraction numbers and MI in each region such that roughly half 
were in each group to relate symptoms to contractility.
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2.3 | Symptom assessment
Symptoms	were	quantified	by	modified	Patient	Assessment	of	Upper	
Gastrointestinal	 Disorders	 Symptoms	 (PAGI-	SYM)	 questionnaires	
enumerating	22	symptoms	from	0	(no	symptoms)	to	5	(most	severe).25 
Overall gastroparesis severity was determined by the Gastroparesis 
Cardinal	Symptom	Index	(GCSI)	score,	which	includes	nine	questions	
from	the	PAGI-	SYM.26	PAGI-	SYM	subscale	scores	for	upper	GI	symp-
toms were calculated for nausea/vomiting, postprandial fullness/early 
satiety, bloating/visible distention, and upper abdominal pain/discom-
fort. The nausea/vomiting subscale score was the mean of scores for 
nausea	[feeling	sick	to	your	stomach	as	if	you	were	going	to	vomit	or	
throw up], retching [heaving as if to vomit, but nothing comes up], and 
vomiting. The postprandial fullness/early satiety subscale score was 
the	mean	of	scores	for	stomach	fullness,	not	able	to	finish	a	normal-	
sized meal, feeling excessively full after meals, and loss of appetite. 
The bloating/visible distention subscale score was the mean of scores 
for	bloating	[feeling	like	you	need	to	loosen	your	clothes]	and	stom-
ach or belly visibly larger. The upper abdominal pain/discomfort sub-
scale score referred to symptoms above the navel, while the lower 
abdominal pain/discomfort subscale score described symptoms below 
the	navel.	PAGI-	SYM	subscale	scores	for	 lower	abdominal	pain/dis-
comfort and individual symptom scores for constipation and diarrhea 
quantified	lower	GI	symptoms.
2.4 | Data comparisons
Delayed	scintigraphic	solid	gastric	emptying	(>10%	4-	hour	retention	
and/or	>60%	2-	hour	retention)	was	compared	in	patients	with	normal	
versus delayed WMC GET to determine agreement between meth-
ods.	Delayed	SBTT	and	CTT	were	related	to	normal	versus	delayed	
GET to correlate gastric emptying with extragastric transit.23 WMC 
gastric, small bowel, and colon contraction numbers and MI were 
compared between normal versus delayed GET to relate contractility 
to gastric emptying. Scintigraphy and WMC measures were compared 
in diabetic versus idiopathic patients to contrast motor abnormalities 
between etiologies. Although their data were incorporated into anal-
yses of the entire cohort, postfundoplication gastroparesis patients 
were not included in subgroup analyses related to etiology due to the 
small	sample	size	(N	=	8).	Data	from	patients	with	rapid	scintigraphic	
gastric	emptying	(<38%	1-	hour	retention),	GET	(N	=	10),	SBTT	(N	=	8),	
and	CTT	 (N	=	6)	were	not	analyzed	separately	due	to	small	samples	
and were pooled in with normal transit groups. To gain insight into 
CUNV	pathogenesis,	GET,	SBTT,	and	CTT	results	were	compared	in	
patients with normal versus delayed solid scintigraphy. Gastric, small 
bowel, and colon contraction numbers and MI were contrasted with 
normal	 and	 delayed	 solid	 scintigraphy	 to	 ascertain	 whether	 CUNV	
presents with specific contractility profiles.
Overall	GCSI	 scores,	 PAGI-	SYM	subscores,	 and	 individual	PAGI-	
SYM lower GI symptoms were compared in those with delayed ver-
sus	normal	GET,	SBTT,	and	CTT	and	with	high	versus	low	numbers	of	
contractions and MI in the hour before and after GET and during the 
period of colon transit.
2.5 | Statistical analyses
Exploratory data analyses using means, medians, standard deviation, 
and	interquartile	ranges	(IQR)	were	applied	to	WMC	and	scintigraphic	
measures and by comparing patients with diabetic versus idiopathic 
gastroparesis, normal versus delayed GET, and normal versus de-
layed scintigraphy. Differences between groups were compared 
using	Wilcoxon	rank-	sum	testing	for	continuous	measures	or	Fisher’s	
F IGURE  1 Representative WMC 
recordings	from	patients	with	(A)	normal	
transit	throughout,	(B)	mildly	delayed	GET,	
(C)	severely	delayed	GET,	(D)	delayed	CTT,	
and	(E)	generalized	GET,	SBTT,	and	CTT	
delays	are	shown	(normal	GET	≤5	h,	normal	
SBTT	≤6	h,	normal	CTT	≤58:45	h).	Transit	
times	are	calculated	from	pH	transitions	
(red	tracings)	and	temperature	changes	
(green	tracings).	Pressure	recordings	are	
shown in blue
Mild GET delay Severe GET delay
Generalized delayCTT delay
Normal transit
Region Time(h:min)
GET 5:32
SBTT 5:24
CTT 44:03
Region Time(h:min)
GET 90:32
SBTT 3:44
CTT 26:57
Region Time(h:min)
GET 10:32
SBTT 13:21
CTT 94:16
Region Time(h:min)
GET 3:13
SBTT 4:57
CTT >136:21
Region Time(h:min)
GET 3:48
SBTT 4:00
CTT 19:39
(A)
(B) (C)
(D) (E)
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exact test for categorical measures. T tests compared symptoms by 
high vs low categories of gastric, small bowel, and colon contractions. 
Patients with normal vs delayed WMC GET were compared graphi-
cally	using	medians	(IQRs)	to	4-	hour	solid	and	1-	hour	liquid	retention	
percentages,	SBTT,	and	CTT.	Symptom	profiles	were	plotted	as	means	
and	95%	confidence	intervals	by	normal	vs	delayed	GET,	SBTT,	and	
CTT.	Nominal,	 two-	sided	P-	values	with	no	adjustments	 for	multiple	
comparisons	 are	 presented;	 comparisons	 were	 hypothesis-	driven.	
Analyses were performed using SAS (version 9.3; SAS Institute, Cary, 
NC,	USA)	and	Stata	 (Release	13,	Stata	Corporation,	College	Station,	
TX,	USA)	software.
3  | RESULTS
3.1 | Transit and contractility abnormalities
Figure	1	shows	recordings	 from	patients	with	 (A)	normal	 transit,	 (B)	
mildly	delayed	GET	 (5	hours,	32	minutes),	 (C)	 severely	delayed	GET	
(90	hours,	 32	minutes),	 (D)	 delayed	 CTT	 (>136	hours,	 21	minutes),	
and	(E)	diffusely	delayed	GET	(10	hours,	32	minutes),	SBTT	(13	hours,	
21	minutes),	and	CTT	(94	hours,	16	minutes).
Transit determinations for the whole group included patients 
with diabetic, idiopathic, and postfundoplication etiologies. 
Delayed	solid	(4-	hour	retention)	and	liquid	(1-	hour	retention)	scin-
tigraphic	gastric	emptying	were	observed	 in	68.8%	and	34.8%	of	
patients,	respectively	(Table	1).	WMC	transit	abnormalities	includ-
ing	 delayed	 and	 rapid	 transit	were	 found	 in	 73.3%.	Delays	were	
noted	 in	66.3%	 including	delayed	GET	 in	40.3%,	 SBTT	 in	15.5%,	
and	CTT	in	33.5%.	Generalized	delays	involving	≥2	of	the	3	regions	
were	observed	in	23.3%.	Severe	GET	delays	were	found	in	28.8%	
of	patients.	Fifty-	eight	of	132	patients	with	delayed	scintigraphy	
had	delayed	WMC	GET	(43.9%	positive	agreement)	while	42	of	60	
with	normal	scintigraphy	had	normal	GET	(70.0%	negative	agree-
ment).	Overall	agreement	between	4-	hour	scintigraphic	retention	
and	GET	was	 52.8%	with	 a	 kappa	 of	 0.12	 (95%	CI	 0.002,	 0.23);	
agreement	between	2	-	hour	 scintigraphic	 retention	and	GET	was	
58.7%	with	a	kappa	of	0.16	(95%	CI	0.02,	0.29).	Rapid	gastric	scin-
tigraphy	was	 found	 in	 6	 of	 188	 (3.2%).	 Rapid	GET	was	 noted	 in	
TABLE  1 Prevalence of transit delays and contractility abnormalities in patients with suspected diabetic or idiopathic gastroparesis
Measure
All patients 
N (%) or Median (IQR)
Diabetic patients 
N (%) or Median (IQR)
Idiopathic patients 
N (%) or Median (IQR)
P value diabetic 
vs idiopathic 
patients
Transit measures
Delayed scintigraphic 4 h solid 
retention	>10%
132/194	(68.8%) 48/66	(72.7%) 84/126	(66.7%) .42
Rapid scintigraphic 1 h solid retention 
<38%
6/188	(3.2%) 4/66	(6.1%) 2/124	(1.6%) .18
Delayed	scintigraphic	1	h	liquid	
retention	>50%
48/137	(34.8%) 14/44	(31.8%) 34/94	(36.2%) .70
Delayed	WMC	GET	>5	h 81/201	(40.3%) 34/66	(51.5%) 42/128	(32.8%) .01
Rapid	WMC	GET	<1:45	h 10/201	(5.0%) 2/66	(3.0%) 8/128	(6.2%) .50
WMC	SBTT	(h) 4.05	(3.19,	5.39) 3.55	(2.85,	4.69) 4.12	(3.30,	5.68) .01
Delayed	WMC	SBTT	>6	h 26/168	(15.5%) 4/49	(8.2%) 21/114	(18.4%) .15
Rapid	WMC	SBTT	<2:15	h 8/168	(4.8%) 4/49	(8.2%) 4/114	(3.5%) .24
WMC	CTT	(h) 41.6	(20.6,	67.7) 45.9	(21.9,	64.0) 38.7	(20.3,	69.2) .73
Delayed	WMC	CTT	>59	h 55/164	(33.5%) 17/49	(34.7%) 36/111	(32.4%) .86
WMC	delays	in	≥2	regions 38/163	(23.3%) 10/47	(21.3%) 26/113	(23.0%) 1.00
Contractility measures
Gastric contractions/h 56	(27,	119) 49	(35,	120) 56	(24,	119) .70
Reduced	gastric	contractions	(<29/h) 41/160	(25.6%) 9/45	(20.0%) 31/107	(29.0%) .31
Gastric	motility	index	(MI) 11.5	(10.3,	12.6) 11.6	(10.4,	12.6) 11.5	(9.9,	12.6) .67
Reduced	gastric	MI	(<9.82) 33/154	(21.4%) 6/45	(13.3%) 26/107	(24.3%) .19
Small bowel contractions/h 137.5	(67,	230) 148	(86,	303) 136	(65,	206) .17
Reduced small bowel contractions 
(<36/h)
20/146	(13.7%) 3/41	(7.3%) 17/105	(16.2%) .19
Small	bowel	motility	index	(MI) 12.7	(11.4,	13.8) 12.9	(11.8,	14.4) 12.6	(11.1,	13.5) .11
Reduced	small	bowel	MI	(<10.57) 24/146	(16.4%) 5/41	(12.2%) 19/105	(18.1%) .46
Colon contractions/h 125	(87,	163) 108	(80,	155) 129	(91,	165) .30
N,	sample	size;	IQR,	interquartile	range.
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10	of	200	(5.0%),	SBTT	in	8	of	168	(4.8%),	and	colon	in	6	of	169	
(3.6%)	patients.
Numbers	of	WMC	contractions	and	MI	in	each	region	are	shown	in	
Table 1. Reduced numbers of gastric contractions and gastric MI were 
found	in	25.6%	and	21.4%,	and	decreased	numbers	of	small	bowel	con-
tractions	and	small	bowel	MI	were	noted	in	13.7%	and	16.4%,	respectively.
Data	 acquisition	 was	 incomplete	 in	 small	 numbers	 of	 patients.	
No	reliable	WMC	transit	data	were	acquired	in	5	of	201	(2.5%).	The	
WMC remained in the stomach during the entire recording in 9 of 196 
(4.6%),	reflecting	profound	GET	delays.	Anal	expulsion	did	not	occur	
during	the	recording	in	34	of	196	(17.3%)	preventing	definitive	CTT	
determination.	However,	 it	was	possible	 to	determine	that	CTT	was	
delayed	 in	24	of	34	 (70.6%)	of	 those	cases	 in	which	anal	 expulsion	
was	not	observed.	Transient	data	loss	was	noted	in	27	of	196	(13.8%)	
preventing accurate transit determination in at least one region.
3.2 | Relation of scintigraphy and WMC measures 
to etiology
Subgroup analyses relating to etiology focused on comparisons be-
tween diabetic versus idiopathic patients and excluded the small 
number of postfundoplication patients. Solid scintigraphic gastric 
retention was greater in diabetic versus idiopathic patients (P	=	.04);	
liquid	 emptying	was	 not	 different	 between	 etiologies	 (Figure	2A,B).	
Diabetics	had	longer	WMC	GETs	(Figure	2C)	(P	=	.02),	and	more	dia-
betics exhibited delayed GETs (P	=	.01)	vs	idiopathic	patients	(P	=	.01)	
(Table	1).	Overall	agreement	between	4-	hour	scintigraphic	retention	
and	GET	 in	diabetics	was	57.6%	with	a	kappa	of	0.14	 (95%	CI	0.0,	
0.36),	while	agreement	in	idiopathic	patients	was	49.2%	with	a	kappa	
of	0.09	(95%	CI	0.0,	0.22).	Agreements	were	not	significantly	differ-
ent between etiologies (P	=	.64).	 Conversely,	 SBTTs	were	 longer	 in	
idiopathic patients (P	=	.01).	 No	 other	WMC	 transit	 or	 contractility	
measure	related	to	etiology	(Table	1).
3.3 | Relation of gastric emptying to other measures
Scintigraphic solid gastric retention was greater in patients with de-
layed	(N	=	118)	vs	normal	(N	=	76)	GET	(P	=	.001)	(Figure	3A).	Liquid	
scintigraphic retention also was higher with delayed GET (P	=	.02)	
(Figure	3B).	 Percentages	 of	 patients	 with	 solid	 scintigraphic	 delays	
trended higher with delayed versus normal GET (P	=	.08);	percentages	
with severely delayed solid emptying were greater with delayed GET 
(P	=	.007)	(Table	2).	Percentages	of	patients	with	delayed	liquid	scin-
tigraphy were similar with delayed and normal GET.
SBTT	and	CTT	values	were	similar	in	patients	with	delayed	(N	=	53)	
vs	normal	(N	=	110)	GET	(Figures	3C,D).	SBTT	delays	(P	=	.04)	but	not	
CTT	delays	were	more	prevalent	among	those	with	GET	delays	(Table	2).
Numbers	of	gastric	contractions	in	the	hour	before	capsule	empty-
ing were lower with delayed GET (P	=	.02)	and	percentages	of	patients	
with low contraction numbers were higher with delayed versus nor-
mal GET (P	=	.0003)	(Table	2).	Gastric	MIs	in	the	hour	before	capsule	
emptying were lower with delayed GET (P	=	.0004),	and	percentages	
with low MI were greater with delayed versus normal GET (P	=	.01).	
Numbers	 of	 colon	 contractions/hour	were	 lower	with	 delayed	GET	
(P	=	.02).	Numbers	of	small	bowel	contractions	and	MI	and	percent-
ages with reductions in small bowel contractions and MI were not dif-
ferent with delayed versus normal GET.
GET,	 SBT,	 and	CTT	values	 and	 percentages	 of	 patients	with	 re-
gional WMC delays were similar with delayed versus normal scinti-
graphic	emptying	(Table	3).	Numbers	of	gastric,	small	bowel,	and	colon	
contractions and MI and percentages with reductions in contractions 
and MI in the three regions were not different with delayed versus 
normal	scintigraphy	(Table	3).
3.4 | Relation of regional transit and contractility 
to symptoms
Overall	 GCSI	 and	 PAGI-	SYM	 subscale	 scores	 for	 nausea/vomit-
ing, early satiety/postprandial fullness, bloating/visible distention, 
and upper and lower abdominal pain/discomfort were not differ-
ent	with	delayed	versus	normal	GET,	SBTT,	 and	CTT	 (Figure	4A-	C).	
Constipation scores were higher in patients with delayed CTT 
(P	=	.03);	diarrhea	scores	were	 lower	 in	patients	with	delayed	SBTT	
(P	=	.04)	and	with	delayed	CTT	(P	=	.01)	(Figure	4D-	F).
PAGI-	SYM	upper	abdominal	pain/discomfort	subscale	scores	were	
greater in patients with higher versus lower numbers of colon con-
tractions (P	=	.03)	(Table	4).	Overall	GCSI	scores	and	nausea/vomiting,	
early satiety/postprandial fullness, and bloating/distention subscale 
scores were not different in relation to any contractility measure. 
Lower abdominal pain/discomfort subscale (P	=	.02)	and	constipation	
scores (P	=	.03)	were	greater	in	those	with	higher	vs	lower	colon	con-
traction numbers.
F IGURE  2 Disease etiologies 
were	related	to	solid	(A)	and	liquid	
(B)	scintigraphic	gastric	emptying	and	
WMC	GET	(C).	Solid	scintigraphic	gastric	
retention (P	=	.02)	and	WMC	GET	(P	=	.04)	
values were greater among diabetic (open 
bars)	versus	idiopathic	(gray	bars)	patients,	
while	liquid	scintigraphic	emptying	was	not	
different between etiologies
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4  | DISCUSSION
This investigation is the largest, most comprehensive prospective 
analysis of gastric plus extragastric transit abnormalities in suspected 
gastroparesis using WMC methods. Although WMCs are employed 
much less often than scintigraphy to measure gastric emptying, our 
sample size compared favorably to many large published studies using 
gastric scintigraphy.27-29 Additional strengths of this study included its 
multicenter structure with recruitment of well characterized patients, 
its separate analyses of diabetic versus idiopathic etiologies, its stand-
ardized analyses of diverse transit and contractility measures, and 
its association of motor findings to symptom profiles using validated 
surveys.
As in the initial study comparing scintigraphic and WMC findings 
in	patients	with	prior	diagnoses	of	gastroparesis,	solid-	phase	gastric	
emptying measured by scintigraphy correlated with WMC GETs in 
F IGURE  3 Solid	(A)	and	liquid	(B)	
gastric emptying were compared with 
normal	(open	bars)	versus	delayed	(gray	
bars)	WMC	GETs.	Solid	(P	=	.001)	and	
liquid	(P	=	.02)	retentions	were	greater	with	
delayed	GETs.	SBTT	(C)	and	CTT	(D)	were	
compared	with	normal	(open	bars)	versus	
delayed	(gray	bars)	GETs.	Extragastric	
transit was not different in relation to GET
0
2
4
6
8
Ti
m
e 
(h
)
SBTT
median (IQR)
Normal GET
Delayed GET
0
20
40
60
80
Ti
m
e 
(h
)
CTT
median (IQR)
Normal GET
Delayed GET
Small bowel transit time Colon transit time
0
10
20
30
40
50
60
(A) (B)
(C) (D)
4-
h 
R
et
en
tio
n 
(%
)
1-
h 
R
et
en
tio
n 
(%
)
Solid phase scintigraphic emptying
median (IQR)
Normal GET
Delayed GET
Solid gastric emptying
P = 0.001
0
15
30
45
60
75
Liquid phase scintigraphic emptying
median (IQR)
Normal GET
Delayed GET
Liquid gastric emptying
P = 0.02
Measure
Normal GET (≤5 h) 
N (%)
Delayed GET (>5 h) 
N (%) P value
Transit measures
Delayed scintigraphic solid gastric 
emptying	(>10%	4-	h	retention)
74/116	(63.8%) 58/76	(76.3%) .08
Severely delayed scintigraphic solid 
gastric	emptying	(>35%	4-	h	retention)
18/116	(15.5%) 25/76	(32.9%) .007
Delayed	scintigraphic	liquid	gastric	
emptying	(>50%	1-	h	retention)
26/84	(31.0%) 22/54	(40.7%) .27
Delayed	WMC	SBTT	(>6	h) 12/110	(10.9%) 13/53	(24.5%) .04
Delayed	WMC	CTT	(>59	h) 36/106	(34.0%) 17/54	(31.5%) .53
Contractility measures
Gastric contractions/h 64	(38,	130) 35	(11,	61) .02
Reduced	gastric	contractions	(<29/h) 18/105	(17.1%) 23/50	(46.0%) .0003
Gastric	motility	index	(MI) 11.7	(10.7,	12.7) 10.6	(8.7,	11.9) .0004
Reduced	gastric	MI	(<9.82) 16/105	(15.2%) 17/50	(34.0%) .01
Small bowel contractions/h 138	(77,	223) 124	(63,	255) .92
Reduced small bowel contractions 
(<36/h)
13/104	(12.5%) 7/45	(15.6%) .81
Small	bowel	motility	index	(MI) 12.7	(11.6,	13.8) 12.6	(11.3,	14.0) .74
Reduced	small	bowel	MI	(<10.57) 16/104	(15.4%) 8/45	(17.8%) .92
Colon contractions/h 130	(91,	192) 115	(86,	139) .02
N,	sample	size
TABLE  2 Relation of WMC GET to 
abnormalities of other measures
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our investigation.5 We expanded on this by showing additional as-
sociations	of	liquid	emptying	with	GETs.	Unexpected	findings	of	the	
present	 investigation	 included	 a	 device	 agreement	 of	 only	 52.8%	
between WMC and scintigraphic gastric emptying measures and a 
lower prevalence of emptying delays with WMC versus nuclear medi-
cine tests. In the original report, correlations were stronger (R	=	0.73)	
and	WMCs	detected	21%	more	delays	than	scintigraphy.5 There are 
several potential explanations for these differences between the 
two studies. Most importantly, WMC and scintigraphic tests were 
performed on separate days in the current investigation while they 
were concurrent in the initial investigation. Coefficients of variabil-
ity	of	up	to	31%	are	seen	on	serial	gastric	emptying	measurements	
regardless of the method of testing, suggesting that emptying rates 
are inconsistent from day to day in health and in gastroparesis.4,5,30 
Thus, much of the disparity between our investigation and the Kuo 
study may relate to different day testing. Secondly, it is established 
that	gastric	emptying	of	digestible	solids	like	the	egg	substitute	meals	
ingested during scintigraphy is mediated by different mechanisms (ie, 
fed	motor	pattern)	 than	 for	 indigestible	 solids	 like	 the	WMC	 (fast-
ing	migrating	motor	 complexes).31,32 This raises the possibility that 
emptying	rates	measured	by	the	two	techniques	may	be	inherently	
different. Thirdly, although the caloric composition of the nutrient 
bars ingested during WMC testing in this study is similar to the egg 
substitute meals consumed with scintigraphy, subtle differences in 
emptying profiles have been reported for the two meals.23	However,	
the magnitude of the difference in gastric emptying rates between 
the	 two	meals	 is	 likely	 too	 small	 to	 explain	 the	disparate	observa-
tions of the current study and the original report. This discrepancy 
will be addressed by ongoing multicenter studies comparing the two 
techniques	when	performed	simultaneously	 in	patients	believed	 to	
have gastroparesis. These large, prospective investigations will de-
finitively determine whether stratification of patients into those with 
and without delayed gastric emptying is substantially different with 
the two methods.
We also confirmed extragastric WMC transit delays previously 
documented in studies employing less rigorous patient characteriza-
tions.13,14	Small	bowel	and	colon	delays	were	 found	 in	>40%	of	pa-
tients	 with	 suspected	 gastroparesis,	 and	 more	 than	 20%	 exhibited	
generalized	 impairments.	 SBTT	 delays	 were	 associated	 with	 GET	
delays suggesting possible common motor impairments across gut 
regions but did not correlate with gastric scintigraphy delays. This 
finding is consistent with the different physiology of indigestible ver-
sus digestible solid emptying.31,32 A novel finding of our study was its 
characterization of rapid transit in different regions in small numbers 
of patients with suspected gastroparesis.23 Others have observed 
rapid	 gastric	 emptying	 in	 up	 to	 41%	 patients	with	 dyspepsia	 using	
Measure
Normal 4- h scintigraphy 
Median (IQR) or N (%)
Delayed 4- h scintigraphy 
Median (IQR) or N (%) P value
Transit measures
WMC	GET	(h) 4.0	(3.0,	14.8) 4.6	(3.2,	14.9) .36
Delayed	WMC	GET	(>5	h) 18/60	(30.0%) 58/132	(44.0%) .09
WMC	SBTT	(h) 4.12	(3.23,	5.43) 3.97	(3.15,	5.37) .49
Delayed	WMC	SBTT	
(>6	h)
9/49	(18.4%) 16/114	(14.0%) .48
WMC	CTT	(h) 38.7	(19.6,	74.0) 41.9	(21.9,	65.0) .65
Delayed WMC CTT 
(>59	h)
18/50	(36.0%) 35/110	(31.8%) .53
Contractility measures
Gastric contractions/h 56.0	(29.0,	104.0) 54.0	(24.0,	120.0) .80
Reduced gastric 
contractions	(<29/h)
9/43	(20.9%) 31/109	(28.4%) .42
Gastric	motility	index	(MI) 11.5	(10.7,	12.5) 11.4	(9.9,	12.6) .40
Reduced gastric MI 
(<9.82)
5/43	(11.6%) 27/109	(24.8%) .08
Small bowel 
contractions/h
155.0	(112.0,	231.0) 129.0	(61.0,	222.0) .24
Reduced small bowel 
contractions	(<36/h)
2/39	(5.1%) 18/107	(16.8%) .10
Small bowel motility 
index	(MI)
12.9	(12.3,	14.0) 12.6	(11.1,	13.9) .16
Reduced small bowel MI 
(<10.57)
3/39	(7.7%) 21/107	(19.6%) .13
Colon contractions/h 138	(90,	162) 126	(84,	162) .55
N,	sample	size;	IQR,	interquartile	range.
TABLE  3 Relation of regional transit 
and contractility to delayed versus normal 
scintigraphic gastric emptying
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F IGURE  4 Overall	GCSI	and	subscale	scores	for	nausea/vomiting	(N/V),	early	satiety/fullness	(Fullness),	bloating/distention	(Bloating),	
and	upper	abdominal	pain/discomfort	(Upper	Pain)	were	not	different	with	delayed	versus	normal	GET,	SBTT,	or	CTT	(A-	C).	Lower	abdominal	
pain/discomfort	subscale	scores	(Lower	Pain)	were	similar	with	delayed	and	normal	GET,	SBTT,	and	CTT.	Constipation	scores	were	higher	with	
delayed CTT (P	=	.03);	diarrhea	scores	were	lower	with	delayed	SBTT	(P	=	.04)	and	CTT	(P	=	.01)	(D-	F)
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TABLE  4 Relation of symptoms to contractility measures
PAGI- SYM symptom 
characteristic
Number of gastric contractions in 
hour before gastric emptying 
(Mean ± SD)
Number of small bowel contractions 
in hour after gastric emptying 
(Mean ± SD)
Number of colon contractions per 
hour (Mean ± SD)
High Low P value High Low P value High Low P value
Upper GI symptoms
Overall GCSI score 2.6 ± 1.0 2.7 ± 1.1 .92 2.6 ± 1.1 2.7 ± 1.0 .66 2.7 ± 1.1 2.4 ± 1.0 .15
Nausea/vomiting	subscore 1.8 ± 1.4 1.7 ± 1.2 .53 1.7 ± 1.3 1.9 ± 1.3 .30 1.9 ± 1.4 1.6 ± 1.2 .32
Postprandial fullness/early 
satiety subscore
3.2 ± 1.3 3.3 ± 1.1 .76 3.2 ± 1.2 3.3 ± 1.1 .65 3.2 ± 1.2 3.1 ± 1.1 .58
Bloating/visible	distention	
subscore
3.0 ± 1.7 3.0 ± 1.6 .93 3.0 ± 1.7 2.9 ± 1.7 .77 3.0 ± 1.7 2.5	±	1.6 .12
Upper abdominal pain/
discomfort subscore
2.6 ± 1.7 2.8 ± 1.4 .52 2.6 ± 1.7 2.8 ± 1.4 .46 3.0 ± 1.4 2.4	±	1.5 .03
Lower GI symptoms
Lower abdominal pain/
discomfort subscore
2.1	±	1.5 1.9	±	1.5 .31 2.1 ± 1.6 1.8 ± 1.4 .34 2.2	±	1.5 1.6 ± 1.3 .02
Constipation score 2.3 ± 1.7 2.8 ± 1.8 .10 2.4 ± 1.7 2.7 ± 1.8 .41 3.1 ± 1.6 2.4 ± 1.7 .03
Diarrhea score 1.6 ± 1.7 1.5	±	1.6 .61 1.7 ± 1.7 1.4 ± 1.6 .18 1.2 ± 1.7 1.8 ± 1.6 .07
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scintigraphy, but none have examined rapid WMC transit.33,34 In this 
investigation,	rapid	transit	was	found	in	too	few	patients	(5%)	for	sub-
group analyses.
Novel	regional	contractility	findings	were	acquired	from	our	WMC	
pressure data. The association of delayed GET with reduced gastric 
but not small bowel contractions contrasts with an earlier study in 
which small bowel and gastric contractility were decreased only with 
GET >12 hours.16	However,	that	investigation	only	included	8	patients	
with	mildly	delayed	GET	(<12	hours)	and	was	too	small	to	be	definitive.	
Decreases in colon contractions related to delayed GET but not scinti-
graphic gastric emptying. Similarly, reduced numbers of colon contrac-
tions were noted in diabetics with delayed GET in post hoc analyses 
of the original WMC investigation, supportive of diffuse dysfunction 
in some patients with gastroparesis symptoms.5,17 The present study 
extended these findings to idiopathic patients. The preservation of 
normal small bowel contractions and MI in those with delayed GET 
suggests this gut region is less susceptible to disruption in patients 
with generalized dysmotility.
Our large sample allowed us to contrast transit and contractility 
in idiopathic disease versus diabetes. Prior studies showed no gastric 
scintigraphy differences between etiologies, but we found more se-
vere emptying delays in diabetics versus idiopathic patients using both 
WMCs and scintigraphy.9	However,	device	agreements	between	scin-
tigraphy and WMCs were similar in diabetic and idiopathic patients. 
Furthermore,	 SBTTs	were	 shorter	 in	diabetics	 than	 in	 idiopathic	pa-
tients.	 Physiologic	 studies	have	noted	differences	 in	 gastric	 pH	and	
pancreatic polypeptide release in diabetic versus idiopathic gastropa-
resis suggesting more severe vagal impairments with diabetes.35,36 
Our findings support differential pathogenesis of transit impairments 
in relation to etiology, perhaps secondary to different degrees of vagal 
dysfunction.
The comprehensive associations of symptoms with transit and 
contractility included in this study complement detailed published 
observations by the Gastroparesis Consortium relating symptoms to 
scintigraphic gastric emptying.18 Gastroparesis symptoms showed lit-
tle correlation with GETs or other WMC transit or contractility mea-
sures; only numbers of colon contractions positively associated with 
upper abdominal pain severity. These findings suggest symptoms of 
gastroparesis are not solely determined by gastric, small intestinal, 
or	colon	transit.	Furthermore,	these	observations	are	at	odds	with	a	
prior smaller study reporting higher global gastroparesis symptoms 
with reduced small bowel contractions.19 Individual symptoms were 
not examined in that previous investigation. Similarly, another study 
employing dichotomous symptom assessments found no symptom 
correlation with WMC measures.12
This	 investigation	 raises	 new	questions	 about	CUNV	pathogen-
esis. We hypothesized that WMC testing would uncover distinct ex-
tragastric transit or contractile profiles in patients with normal gastric 
scintigraphy given the symptom overlaps of gastroparesis and the 
lower functional bowel disorders.8,9	However,	no	WMC	small	bowel	
or colon transit or contractility abnormalities were specific for those 
with normal scintigraphy suggesting that no regional transit or pha-
sic	motor	pattern	 is	definitive	for	symptom	genesis	 in	CUNV.	These	
findings warrant consideration of other pathophysiologic contributors 
including impaired gastric accommodation, altered luminal sensa-
tion, myoelectric dysfunction, or central nervous system abnormal-
ities	not	detectable	by	gastric	emptying	 testing	as	causes	of	CUNV	
pathogenesis.37-39
Our analyses associated lower GI symptoms in patients with sus-
pected gastroparesis to WMC transit and contractility. In contrast 
to	gastroparesis	 symptoms,	diarrhea	 related	 to	 rapid	SBTT	and	CTT	
while constipation scores were higher in those with delayed CTT and 
increased colon contractions and lower abdominal pain correlated 
with higher colon contractility. These findings parallel a prior WMC 
study,	in	which	patients	with	constipation-	predominant	irritable	bowel	
syndrome showed greater contractility than those with functional 
constipation.24
This investigation had limitations. Although most agents af-
fecting transit were discontinued for study conduct, some main-
tenance	medications	(eg	antihypertensives,	antidepressants)	might	
have	 influenced	WMC	measures.	Because	patients	 returned	data	
recorders	4-	7	days	 after	WMC	 ingestion,	 definitive	CTT	determi-
nation	was	not	possible	in	some	individuals.	However,	in	more	than	
two-	thirds	of	these	patients,	we	were	still	able	to	diagnose	delayed	
CTT. It would have been impractical to lengthen the data collection 
period to define CTT in the remainder. Glycemic control was not 
monitored in diabetics; thus, acute hyperglycemic effects on transit 
or contractility cannot be excluded.40	Despite	drawbacks,	these	im-
portant findings provide a foundation for additional investigations 
defining impacts of WMC performance on patient management. 
As with other methods of emptying testing including scintigraphy, 
there are few published studies which objectively demonstrate that 
quantifying	the	rate	of	gastric	emptying	influences	any	symptom	or	
resource	utilization	outcome	in	suspected	gastroparesis.	However	
in	one	 investigation,	 scintigraphic	gastric	 retention	>20%	was	as-
sociated with superior outcomes versus milder impairments sup-
porting the utility of emptying testing.41	Future	studies	will	define	
whether WMC testing leads to different treatment decisions versus 
scintigraphy.	Further,	 it	 is	uncertain	whether	 treating	small	bowel	
or colon transit or contractility abnormalities detected by WMC 
testing has additional impact on patient outcomes. In an uncon-
trolled pediatric study, osmotic laxatives reduced gastric emptying 
delays and improved dyspeptic symptoms in children with func-
tional dyspepsia.42 Larger controlled trials could validate the con-
cept that gastroparesis improves with treatments targeting distal 
gut dysfunction.
In conclusion, WMCs define similar but not identical gastric emp-
tying delays as scintigraphy which are more severe in diabetics and 
correlate with reduced gastric and colon contractility. Extragastric or 
generalized	transit	delays	occur	in	>40%	of	patients	with	gastroparesis	
symptoms. Upper GI symptoms correlate poorly with WMC defects 
and	do	not	distinguish	gastroparesis	 from	CUNV,	although	 lower	GI	
symptoms associate with transit and contractility abnormalities. These 
findings provide insight into gastroparesis pathogenesis and form a 
basis for future investigations studying the impact of WMC testing 
on clinical care.
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